E Despaux

574 total citations
20 papers, 488 citations indexed

About

E Despaux is a scholar working on Molecular Medicine, Pharmacology and Endocrinology. According to data from OpenAlex, E Despaux has authored 20 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Medicine, 6 papers in Pharmacology and 5 papers in Endocrinology. Recurrent topics in E Despaux's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Bacterial Identification and Susceptibility Testing (3 papers). E Despaux is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Bacterial Identification and Susceptibility Testing (3 papers). E Despaux collaborates with scholars based in France, Netherlands and Tunisia. E Despaux's co-authors include Christian Roumestand, Gérard Grassy, André Aumelas, L. Chiche, Bernard Calas, Alain Chavanieu, Matteo E. Mangoni, M Ramuz, Catherine Neuwirth and N. Bouziges and has published in prestigious journals such as FEBS Letters, Kidney International and Journal of Clinical Microbiology.

In The Last Decade

E Despaux

18 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Despaux France 7 246 226 110 70 65 20 488
M. W. Fisher United States 10 155 0.6× 92 0.4× 143 1.3× 97 1.4× 63 1.0× 19 501
Linda A. Kirven United States 9 115 0.5× 177 0.8× 185 1.7× 35 0.5× 116 1.8× 9 492
A. Alev Gerçeker Türkiye 12 217 0.9× 135 0.6× 94 0.9× 51 0.7× 22 0.3× 14 467
E. Hannecart-Pokorni France 12 138 0.6× 33 0.1× 123 1.1× 24 0.3× 49 0.8× 20 321
Amanda Miller United States 9 331 1.3× 49 0.2× 310 2.8× 24 0.3× 89 1.4× 11 591
E Schütze Austria 13 67 0.3× 79 0.3× 42 0.4× 155 2.2× 12 0.2× 38 432
W. Love United Kingdom 10 143 0.6× 67 0.3× 75 0.7× 9 0.1× 32 0.5× 21 382
S Kuwahara Japan 11 100 0.4× 30 0.1× 147 1.3× 36 0.5× 87 1.3× 18 415
Akshay Sabnis United Kingdom 7 195 0.8× 104 0.5× 269 2.4× 17 0.2× 80 1.2× 11 465
J V Desiderio United States 10 124 0.5× 37 0.2× 46 0.4× 108 1.5× 15 0.2× 12 417

Countries citing papers authored by E Despaux

Since Specialization
Citations

This map shows the geographic impact of E Despaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Despaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Despaux more than expected).

Fields of papers citing papers by E Despaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Despaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Despaux. The network helps show where E Despaux may publish in the future.

Co-authorship network of co-authors of E Despaux

This figure shows the co-authorship network connecting the top 25 collaborators of E Despaux. A scholar is included among the top collaborators of E Despaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Despaux. E Despaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marchandin, Hélène, et al.. (1996). Comparative evaluation of blood culture using the Vital automated system and the Becton-Dickinson Septi-Chek BHI-S biphasic and Sch bottles.. PubMed. 54(3-4). 159–63. 2 indexed citations
2.
Mangoni, Matteo E., André Aumelas, Pierre Charnet, et al.. (1996). Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation. FEBS Letters. 383(1-2). 93–98. 116 indexed citations
3.
Mercatello, A., et al.. (1996). Concentration of teicoplanin in the serum of adults with end stage chronic renal failure undergoing treatment for infection. Journal of Antimicrobial Chemotherapy. 37(5). 1017–1021. 6 indexed citations
4.
Aumelas, André, Matteo E. Mangoni, Christian Roumestand, et al.. (1996). Synthesis and Solution Structure of the Antimicrobial Peptide Protegrin‐1. European Journal of Biochemistry. 237(3). 575–583. 159 indexed citations
5.
Hillaire‐Buys, Dominique, Hélène Peyrière, E. Lobjoie, et al.. (1995). Influence of arterio‐venous haemofiltration on teicoplanin elimination.. British Journal of Clinical Pharmacology. 40(1). 95–97. 9 indexed citations
6.
Marchandin, Hélène, et al.. (1995). Detection kinetics for positive blood culture bottles by using the VITAL automated system. Journal of Clinical Microbiology. 33(8). 2098–2101. 13 indexed citations
7.
Gouby, A, Catherine Neuwirth, Gisèle Bourg, et al.. (1994). Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. Journal of Clinical Microbiology. 32(2). 301–305. 115 indexed citations
8.
Bompart, Jacques, et al.. (1991). Synthèse et activité anti-bactérienne d'acides 4,7-dihydro-4-éthyl-7-oxothiéno(3,2-b)pyridine-6-carboxyliques. European Journal of Medicinal Chemistry. 26(1). 3–11. 25 indexed citations
9.
Arnulf, Bertrand, F Janbon, E Despaux, O. Jonquet, & Jacques Reynes. (1987). [Ofloxacin (RU 43280). Clinical study].. PubMed. 35(5). 629–33. 3 indexed citations
10.
Despaux, E, et al.. (1982). [Pharmacokinetic and clinical investigation of amoxicillin administered intravenously in the newborn ].. PubMed. 30(6 Pt 2). 476–80. 3 indexed citations
11.
Mion, C, et al.. (1979). Reduction in incidence of peritonitis (P) associated with continuous ambulatory peritoneal dialysis (CAPD).. PubMed. 9. 9–14. 5 indexed citations
12.
Despaux, E, et al.. (1977). Salmonelloses humaines et salmonella isolées des eaux dans le département de l'Hérault durant une période de 12 mois. Médecine et Maladies Infectieuses. 7(3). 153–157. 2 indexed citations
13.
Despaux, E, et al.. (1975). A propos de 12 cas de listériose chez l'adulte. Médecine et Maladies Infectieuses. 5(7). 380–384. 1 indexed citations
14.
Despaux, E, et al.. (1974). Les septicémies à Ristella fragilis. Médecine et Maladies Infectieuses. 4(6). 275–282. 2 indexed citations
15.
Despaux, E, et al.. (1973). Traitement antibiotique de l'infection bronchique au cours des bronchites chroniques.. 29(4). 2 indexed citations
16.
Atkins, Robert C., et al.. (1973). Peritoneal transfer of kanamycin and its use in peritoneal dialysis. Kidney International. 3(6). 391–396. 21 indexed citations
17.
Arnulf, Bertrand, et al.. (1973). [Antibiotic treatment of bronchial infections during chronic bronchitis].. PubMed. 29(4). 449–63. 1 indexed citations
18.
Clot, J, et al.. (1971). [Epidemic of A2 Hong-Kong influenza in Montpellier (winter 1969-70)].. PubMed. 79(7). 294–294. 1 indexed citations
19.
Despaux, E, et al.. (1966). Importance pratique de certaines entérobactéries en pathologie humaine.. La Presse Médicale. 74(8). 1 indexed citations
20.
Despaux, E, et al.. (1966). [Practical importance of certain Enterobacteriaceae in human pathology].. PubMed. 74(8). 367–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026